Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kayoko Okamoto is active.

Publication


Featured researches published by Kayoko Okamoto.


Archives of Gerontology and Geriatrics | 1989

Effects of idebenone and related compounds on respiratory activities of brain mitochondria, and on lipid peroxidation of their membranes

Isuke Imada; Takeshi Fujita; Yasuo Sugiyama; Kayoko Okamoto; Yuko Kobayashi

The oxidation of succinate and NADH in a ubiquinone-depleted canine brain mitochondrial preparation was restored by a low molecular weight benzoquinone, idebenone. Idebenone inhibited NADH(NADPH)/ADP-Fe3+-dependent lipid peroxidation in canine brain mitochondria and protected against the resulting inactivation of NADH-cytochrome c reductase activity. Idebenone did not affect the activities of succinate oxidase in canine and rat brain mitochondria but suppressed the oxygen consumption in NADH oxidation. This suppression might be related to the inhibition of lipid peroxidation. These results suggest that idebenone functions as an electron carrier in the respiratory chains of brain mitochondria and as an antioxidant against membrane damage caused by lipid peroxidation in brain mitochondria.


Japanese Journal of Cancer Research | 1992

Therapeutic Effect of Ansamitocin Targeted to Tumor by a Bispecific Monoclonal Antibody

Kayoko Okamoto; Kaori Harada; Shuichi Ikeyama; Susumu Iwasa

We have constructed a murine hybrid hybridoma that secretes a bispecific monoclonal antibody (mAb) by fusing a hybridoma secreting an anti‐ansamitocins mAb with a hybridoma secreting an anti‐human transferrin receptor (TfR) mAb that binds to human A431 epidermoid carcinoma cells. The bispecific mAb, reactive to both ansamitocins and TfR, was purified by a combination of hydrophobic column chromatography and hydroxyapatite high‐performance liquid chromatography, and evaluated in in vivo experiments using human tumor cell‐implanted nude mice. Ansamitocin P‐3 targeted through one of the antigen combining sites of the bispecific mAb was potentially more effective in suppressing the growth of established A431 tumor xenografts implanted on nude mice than unconjugated ansamitocin P‐3 or the immunoconjugate of ansamitocin P‐3 and monospecific anti‐ansamitocins antibody, and the targeted ansamitocin P‐3 finally eradicated the tumor mass. The bispecific mAb also played an important role in reducing such undesirable side‐effects of ansamitocin P‐3 as the loss of body weight, the damage to liver functions and the decrease in the number of white blood cells.


Biochimica et Biophysica Acta | 1982

Effects of Q metabolites and related compounds on mitochondrial succinate and NADH oxidase systems

Kayoko Okamoto; Mitsuru Kawada; Masazumi Watanabe; Shigeru Kobayashi; Isuke Imada; Hiroshi Morimoto

The effects of Q metabolites (Q acid-I, Q acid-II) and related compounds (dihydro Q acid-I, dehydro Q acid-II, QS-n, and their esters) on mitochondrial succinate and NADH oxidase systems were investigated. The activity restoring succinate oxidation in acetone-treated beef heart mitochondria was found to decrease with descending order of carbon number (n) of the side chain of the Q metabolites; activity was restored with Q acid-I (n = 7) to one-third as much as that with Q-7 and Q-10, but Q acid-II (n = 5) did not restore any activity. Of the related compounds with a carboxyalkyl group (QS-n), QS-16-QS-18 (n = 16-18) were found to be most active, and their activities were also correlated with n. The relationship between the restoration of activity and the partition coefficient was considered. NADH oxidation in pentane-treated beef heart submitochondrial particles could be restored with esters of low molecular weight quinones to the same extent as with Q-10, but not with the metabolites.


Archive | 1994

Method of producing sustained-release preparation

Kayoko Okamoto; Yutaka Yamagata; Yasutaka Igari; Masafumi Misaki


Journal of pharmacobio-dynamics | 1985

Effects of idebenone (CV-2619) and its metabolites on respiratory activity and lipid peroxidation in brain mitochondria from rats and dogs.

Yasuo Sugiyama; Takeshi Fujita; Mutsuko Matsumoto; Kayoko Okamoto; Isuke Imada


Chemical & Pharmaceutical Bulletin | 1982

Synthesis of Quinones having Carboxy- and Hydroxy-Alkyl Side Chains, and Their Effects on Rat-Liver Lysosomal Membrane

Kayoko Okamoto; Masazumi Watanabe; Mitsuru Kawada; Giichi Goto; Yasuko Ashida; Katsuaki Oda; Akiko Yajima; Isuke Imada; Hiroshi Morimoto


Archive | 1995

Matrix for sustained-release preparation

Yasutaka Igari; Akira Saikawa; Kayoko Okamoto; Shigeru Kamei; Masahisa Oka; Atsunori Sano


Chemical & Pharmaceutical Bulletin | 1985

Effects of 6-(ω-Substituted Alkyl)-2, 3-dimethoxy-5-methyl-1, 4-benzoquinones and Related Compounds on Mitochondrial Succinate and Reduced Nicotinamide Adenine Dinucleotide Oxidase Systems

Kayoko Okamoto; Mutsuko Matsumoto; Masazumi Watanabe; Mitsuru Kawada; Tetsuji Imamoto; Isuke Imada


Archive | 1998

Production of sustained release preparation

Yasutaka Igari; Kayoko Okamoto; Masafumi Omae; Yutaka Yamagata; 豊 山縣; 加世子 岡本; 雅文 御前; 康孝 猪狩


Archive | 1990

Biospecific antibody to cancer cell and enzyme with prodrug-activating characteristics

Susumu Iwasa; Kayoko Okamoto

Collaboration


Dive into the Kayoko Okamoto's collaboration.

Top Co-Authors

Avatar

Yasutaka Igari

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Yutaka Yamagata

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Isuke Imada

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Kazumichi Yamamoto

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Masazumi Watanabe

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Akira Saikawa

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Hiroshi Morimoto

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Masafumi Misaki

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Mitsuru Kawada

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Shigeru Kamei

Takeda Pharmaceutical Company

View shared research outputs
Researchain Logo
Decentralizing Knowledge